Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta

Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta

Florian Castrop, Bernhard Haslinger, Bernhard Hemmer, Dorothea Buck Department of Neurology, Technische Universität München, Munich, Germany Abstract: Multiple sclerosis (MS) is a common neurological disease with increasing incidence and prevalence. Onset of disease is most frequen...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Castrop F, Haslinger B, Hemmer B, Buck D
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2013
Materias:
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/a102b9304f3a4140a948739e850e1b16
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/a102b9304f3a4140a948739e850e1b16

Ejemplares similares